Brevital Sodium
- Product NDC
- 42023-105
- 11-digit product format
- 420230105
- Labeler code
- 42023
- Product ID
- 42023-105_6efcbde7-9a3d-4d12-93ea-793a9e72725a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methohexital sodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; RECTAL
- Labeler
- Par Health USA, LLC
- Application
- NDA011559
- Marketing category
- NDA
- Marketing start
- 2007-11-01
- Substance
- METHOHEXITAL SODIUM
- Active strength
- 500 mg/1
- Pharmacologic classes
- Barbiturate [EPC], Barbiturates [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Brevital Sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METHOHEXITAL SODIUM | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 60200PNZ7Q |
| Rxcui | 1244233, 1244638 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42023-105-01 | Brevital Sodium | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 18 |
| 42023-105-01 | Brevital Sodium | 1 in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 1 | | 18 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| methohexital sodium | ACTIVE INGREDIENT | 60200PNZ7Q | BREVITAL SODIUM (METHOHEXITAL SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PAR PHARMACEUTICAL, INC.] | 6 | |
| methohexital | ACTIVE MOIETY | E5B8ND5IPE | BREVITAL SODIUM (METHOHEXITAL SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PAR PHARMACEUTICAL, INC.] | 6 | |
| SODIUM CARBONATE | INACTIVE INGREDIENT | 45P3261C7T | BREVITAL SODIUM (METHOHEXITAL SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PAR PHARMACEUTICAL, INC.] | 6 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | BREVITAL SODIUM (METHOHEXITAL SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PAR PHARMACEUTICAL, INC.] | 6 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42023-105 | BREVITAL SODIUM (METHOHEXITAL SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ENDO USA, INC.] | 16 | Current NDC, Legacy NDC, 2 package rows | 20240913_eccd8340-ead3-4363-8902-0c19d33aa2ac.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42023-105-01 | 42023010501 | 1 VIAL in 1 CARTON (42023-105-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL | 1 vial | 2007-11-01 | 0000-00-00 | No | No | Current |